Markets:

Overview

News

Currencies

International

Treasuries

Cardiovascular Systems, Inc. - Common Stock (NQ:CSII)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 27, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cardiovascular Systems, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Cardiovascular Systems, Inc. Announces Development of Intravascular Lithotripsy Technology for the Treatment of Coronary and Peripheral Artery Diseases

January 13, 2022

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems Recalls Embolic Protection Devices Due To Filter Breakage ↗

January 12, 2022

Cardiovascular Systems Inc (NASDAQ: CSII) is recalling all of its Wirion embolic protection system devices manufactured and distributed between January and November...

Via Benzinga

CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3

January 06, 2022

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3

January 06, 2022

From Cardiovascular Systems, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

Cardiovascular Systems Recalls Wirion Embolic Protection System ↗

November 26, 2021

Cardiovascular Systems Inc (NASDAQ: CSII) has commenced a voluntary recall of its WIRION Embolic Protection Systems (WIRION). The unused WRN-D6 models of the...

Via Benzinga

Topics Product Recall

Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2021 ↗

November 17, 2021

Upgrades According to Williams Capital, the prior rating for On Holding AG (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2021 ↗

November 10, 2021

Upgrades HC Wainwright & Co. upgraded the previous rating for BioNTech SE (NASDAQ:

Via Benzinga

75 Biggest Movers From Yesterday ↗

November 10, 2021

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...

Via Benzinga

Cardiovascular Systems, inc (CSII) Q1 2022 Earnings Call Transcript ↗

November 09, 2021

CSII earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Cardiovascular Systems, Inc. Reports Fiscal 2022 First Quarter Financial Results

November 09, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

Cardiovascular Systems, Inc. Announces First In-Human Experience With Coronary Everolimus Drug Coated Balloon

November 04, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Participate at the Stifel 2021 Virtual Healthcare Conference

November 02, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Webcast Fiscal 2022 First-Quarter Earnings Conference Call Tuesday, November 9

October 11, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. Announces First Patient Treated with ViperCross™ Peripheral Support Catheter

September 29, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology ↗

October 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout ↗

October 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (...

Via Benzinga

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data ↗

September 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...

Via Benzinga

Cardiovascular Systems Expects COVID-19 Impact On Quarterly Revenue ↗

September 22, 2021

Cardiovascular Systems Inc (NASDAQ: CSII) issued an update on financials citing the COVID-19 impact. The device maker says that the revenue for Q1 FY22 could be negatively...

Via Benzinga

First Patients in Canada Treated With Cardiovascular Systems, Inc. Diamondback 360® Coronary Orbital Atherectomy System

August 30, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, inc (CSII) Q4 2021 Earnings Call Transcript ↗

August 04, 2021

CSII earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Cardiovascular Systems, Inc. Reports Fiscal 2021 Fourth Quarter and Full Year Financial Results

August 04, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August

July 27, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Webcast Fiscal 2021 Fourth-Quarter Earnings Conference Call Wednesday, August 4

July 14, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. to Participate at the Raymond James Human Health Innovations Conference

June 02, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Cardiovascular Systems, Inc. Announces U.S. Commercial Launch of JADE Over-the-Wire Non-Compliant Peripheral Balloon Catheters

June 01, 2021

From Cardiovascular Systems, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.